Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study
Titel:
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study
Auteur:
Merseburger, Axel S Attard, Gerhardt Åström, Lennart Matveev, Vsevolod B Bracarda, Sergio Esen, Adil Feyerabend, Susan Senkus, Elżbieta López-Brea Piqueras, Marta Boysen, Gunther Gourgioti, Georgia Martins, Karla Chowdhury, Simon